PNC Financial Services Group’s Definium Therapeutics DFTX Stock Holding History

PNC Financial Services Group’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Buy	8,569 +949	+12%	+$23.5K	﹤0.01%	1951
2026 Q1	$144K	Buy	7,620 +532	+8%	+$9.03K	﹤0.01%	2561
2025 Q4	$94.9K	Buy	7,088 +7,059	+24,341%	+$87.4K	﹤0.01%	2835
2025 Q3	$342	Buy	29 +12	+71%	+$112	﹤0.01%	4863
2025 Q2	$110	Buy	+17	New	+$112	﹤0.01%	4831
2022 Q4	–	Sell	-13,535	Closed	-$47K	–	4827
2022 Q3	$47K	Sell	13,535 -1	-0%	-$10	﹤0.01%	3014
2022 Q2	$130K	Buy	+13,536	New	+$171K	﹤0.01%	2401
2022 Q1	–	Sell	-160	Closed	-$3K	–	4641
2021 Q4	$3K	Hold	160	–	–	﹤0.01%	4081
2021 Q3	$5K	Hold	160	–	–	﹤0.01%	3941
2021 Q2	$8K	Buy	+160	New	+$8.4K	﹤0.01%	3768

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

PNC Financial Services Group's DFTX Position: Q2 2026 in Review

PNC Financial Services Group increased its Definium Therapeutics (DFTX) stake by 12% in Q2 2026, buying an estimated $23.5K and bringing the position to 8,569 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #1951.

PNC Financial Services Group first reported a position in DFTX in Q2 2021 and has held it in 10 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

PNC Financial Services Group held 8,569 shares of Definium Therapeutics worth $403K as of Q2 2026.
PNC Financial Services Group bought 949 Definium Therapeutics shares in Q2 2026, an estimated $23.5K.
Definium Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1951 holding.
PNC Financial Services Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 10 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.